Oral Iron for Erythropoietic Protoporphyrias

Completed · Not applicable

Conditions studied: Erythropoietic Protoporphyria, EPP, X-linked Protoporphyria, XLP

In brief

In the medical literature there are conflicting reports on whether iron improves symptoms in patients with EPP and XLP. Giving iron to people who are iron deficient is thought to improve EPP symptoms. However, this has never been systematically tested. Therefore, the purpose of this study is to determine the effect of oral iron for EPP and XLP patients.

Key facts

Study ID
NCT02979249
Run by
Icahn School of Medicine at Mount Sinai
People needed
16
Starts
2016-12-01
Expected to finish
2019-07-19
Last updated by the study team
2020-09-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.